- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04078347
Infrared Thermography to Evaluate the Effect of Paravertebral Block
January 8, 2021 updated by: Wei Mei, Huazhong University of Science and Technology
Changes of Skin Temperature for Evaluation of Paravertebral Block: A Prospective Observational Study Using Infrared Thermography
The aim of this prospective observational study was to evaluate the changes of skin temperature after the paravertebral block measured by infrared thermography.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Methods: Patients scheduled for elective surgery with paravertebral block will receive infrared thermography measures 5 min before the block and continous to 20 min after the block.
The sensitivity, specificity of infrared thermography as diagnostic methods will be determined by receiver operator characteristic analysis.
Study Type
Observational
Enrollment (Actual)
61
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Hubei
-
Wuhan, Hubei, China, 430030
- Tongji Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 70 years (Adult, Older Adult)
Accepts Healthy Volunteers
N/A
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
Patients scheduled for elective surgery with planned paravertebral block for multimodel analgesia.
Description
Inclusion Criteria:
- With informed consent
- American Society of Anesthesiologists physical status Ⅰ-Ⅱ
- Undergo elective surgery with planned paravertebral block
Exclusion Criteria:
- Refusal to participate in the study
- pre-existing infection at the block site
- younger than 18-yr-old
- BMI>35
- significant thoracic kyphoscoliosis
- Those who had taken vasodilatory drugs before surgery
- history of previous thoracic or breast surgery
- Preoperative analgesic medications
- Any contraindications to peripheral nerve block such as coagulation abnormalities, allergy to local anaesthetics, peripheral neuropathy.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Case-Control
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Successful Paravertebral block
Pinprick test was evaluated at 20 min after Paravertebral block.
Pinprick sensation was assessed using a 22-gauge short bevel needle from T2 to T10 at midclavicular line bilaterally .
Pinprick response was recorded quantitatively as 1 (sensation) or 0 (no sensation/numb).
Successful block was defined as the pinprick score was 0 at 20 min after block.
Otherwise, it was defined as a failed block.
|
Paravertebral block is performed at T4 and T5 level under realtime ultrasound guidenance with 10ml of 0.5% ropivacaine for each block, respectively.
|
|
Failed Paravertebral block
Pinprick test was evaluated at 20 min after Paravertebral block.
Pinprick sensation was assessed using a 22-gauge short bevel needle from T2 to T10 at midclavicular line bilaterally .
Pinprick response was recorded quantitatively as 1 (sensation) or 0 (no sensation/numb).
Successful block was defined as the pinprick score was 0 at 20 min after block.
Otherwise, it was defined as a failed block.
|
Paravertebral block is performed at T4 and T5 level under realtime ultrasound guidenance with 10ml of 0.5% ropivacaine for each block, respectively.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes of skin temperature
Time Frame: From baseline up to 20 minutes after block
|
Changes of skin temperature determined by infrared thermography
|
From baseline up to 20 minutes after block
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Noinvasive blood pressure
Time Frame: From baseline up to 20 minutes after block
|
Vital signs
|
From baseline up to 20 minutes after block
|
|
Heart rate
Time Frame: From baseline up to 20 minutes after block
|
Vital signs
|
From baseline up to 20 minutes after block
|
|
SPO2
Time Frame: From baseline up to 20 minutes after block
|
vital signs
|
From baseline up to 20 minutes after block
|
|
Sensory block level
Time Frame: From baseline up to 20 minutes after block
|
Sensory block level determined by pinprick.
|
From baseline up to 20 minutes after block
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Wei Mei, Huazhong University of Science and Technology
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 1, 2019
Primary Completion (Actual)
August 30, 2020
Study Completion (Actual)
October 31, 2020
Study Registration Dates
First Submitted
August 6, 2019
First Submitted That Met QC Criteria
September 3, 2019
First Posted (Actual)
September 6, 2019
Study Record Updates
Last Update Posted (Actual)
January 12, 2021
Last Update Submitted That Met QC Criteria
January 8, 2021
Last Verified
November 1, 2020
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- TJ-IRB20190424
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
IPD Plan Description
For patient's privacy
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Paravertebral Block
-
Assiut UniversityRecruiting
-
Saglik Bilimleri Universitesi Gazi Yasargil Training...Not yet recruiting
-
Kafrelsheikh UniversityCompletedAnalgesia | Erector Spinae Plane Block | Quadratus Lumborum Block | Paravertebral BlockEgypt
-
Medical University of GdanskCompletedQT Interval | Paravertebral BlockPoland
-
Adiyaman University Research HospitalNot yet recruitingCoronary Artery Bypass Surgery | Paravertebral Block
-
Cui XuleiCompletedAnalgesia | Hepatectomy | Paravertebral Block | Postoperative RecoveryChina
-
Cairo UniversityAbdelhamid, Bassant Mohamed, M.D.; Mohamed, Ahmed A., M.D.; Hala Mostafa Gomaa; Mohamed saeid AliCompletedUltrasound Guided L1,L2 Paravertebral BlockEgypt
-
Peking University First HospitalCompletedAnalgesia | Paravertebral Block | Regional Block | Local AnestheticsChina
-
Centre hospitalier de l'Université de Montréal...RecruitingThoracic Surgery | Paravertebral Block | Video-assistedCanada
Clinical Trials on Paravertebral block at T4 and T5 level
-
University Hospital, RouenCompletedAnesthesia | Video Assisted ThoracoscopyFrance
-
Tanta UniversityCompleted
-
University College Hospital GalwayUnknownMastectomy | Regional Anaesthesia | Breast-Conserving SurgeryIreland
-
University Hospital PadovaNot yet recruitingIntubation | Neonatal Disease
-
Aga Khan University Hospital, PakistanCompletedPain, Postoperative | Thoracotomy | Nerve BlockPakistan
-
National Cancer Institute, EgyptRecruiting
-
Ciusss de L'Est de l'Île de MontréalRecruitingBreast Cancer | Breast Neoplasms | Breast Neoplasm Female | Cancer, BreastCanada
-
Shanghai 6th People's HospitalCompleted
-
Istanbul UniversityCompletedPain, PostoperativeTurkey